Application 020313
- Type
- NDA
- Sponsor
- MYLAN IRELAND LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | MIACALCIN | CALCITONIN SALMON | SPRAY, METERED;NASAL | 200 IU/SPRAY | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020313-002 | MIACALCIN | CALCITONIN SALMON | 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED / NASAL | RLD | 1995-08-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020313-002 | MIACALCIN | 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED / NASAL | RLD | 1995-08-17 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020313-002 | MIACALCIN | 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED / NASAL | RLD | 1995-08-17 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020313-002 | MIACALCIN | 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED / NASAL | RLD | 1995-08-17 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020313-002 | MIACALCIN | 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED / NASAL | RLD | 1995-08-17 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calcitonin Salmon | CALCITONIN SALMON | Apotex Corp. | c82eb602-12e1-692b-d660-f8d5b5736b54 | 2026-09-10 | Warnings, Adverse reactions | CALCITONIN SALMON |
| Calcitonin Salmon | CALCITONIN SALMON | Fresenius Kabi USA, LLC | 2b8c6917-c217-45bf-a0ac-a2fa0f7d497a | 2026-07-15 | Warnings, Adverse reactions | CALCITONIN SALMON |
| CALCITONIN SALMON | CALCITONIN SALMON | Par Health USA, LLC | a6eaedb3-5c96-4859-be43-a48c9c818bc7 | 2026-06-29 | Warnings, Adverse reactions | CALCITONIN SALMON |
| CALCITONIN SALMON | CALCITONIN SALMON | Zydus Lifesciences Limited | 6a0fdcc3-9dca-4936-8601-9ec87457263d | 2026-03-06 | CALCITONIN SALMON | |
| CALCITONIN SALMON | CALCITONIN SALMON | Zydus Pharmaceuticals USA Inc. | 0365ebf8-0cb6-49ce-bfde-707d42b9ab00 | 2026-03-06 | Warnings, Adverse reactions | CALCITONIN SALMON |
| Calcitonin Salmon | CALCITONIN SALMON | Dr. Reddy's Laboratories, Inc. | 26f19d56-44fd-dc7a-46e8-afaaaba5734f | 2025-09-17 | Warnings, Adverse reactions | CALCITONIN SALMON |
| Calcitonin Salmon | CALCITONIN SALMON | Sagent Pharmaceuticals | fb76f8db-9288-4297-9780-f02e3bece9a3 | 2025-09-09 | Warnings, Adverse reactions | CALCITONIN SALMON |
| CALCITONIN SALMON | CALCITONIN SALMON | Cipla USA Inc. | 97a1efc7-ff5a-43e5-bf9c-0d66dbe7e6d9 | 2025-07-30 | Warnings, Adverse reactions | CALCITONIN SALMON |
| Miacalcin | CALCITONIN SALMON | Mylan Institutional LLC | 26caf31f-7f7c-48a8-a1ac-35d2ceefda2b | 2024-09-15 | Warnings, Adverse reactions | Miacalcin CALCITONIN SALMON |
| Miacalcin | CALCITONIN SALMON | Mylan Institutional LLC | 753ecc6a-07be-4fc6-9032-cc6ad116a662 | 2024-09-15 | Warnings, Adverse reactions | Miacalcin CALCITONIN SALMON |
| Calcitonin Salmon | CALCITONIN SALMON | Hikma Pharmaceuticals USA Inc. | 7d4507aa-8e10-44a6-bc6e-3176aa8b23cc | 2024-07-10 | Warnings, Adverse reactions | CALCITONIN SALMON |
| Miacalcin | CALCITONIN SALMON | Mylan Institutional LLC | 89cd4f46-b88a-4c10-b25c-47352280dc4e | 2024-04-15 | Warnings, Adverse reactions | Miacalcin CALCITONIN SALMON |
| calcitonin salmon | CALCITONIN SALMON | Amneal Pharmaceuticals LLC | 22f2986f-309c-4133-9e92-1c040453f340 | 2021-11-30 | Warnings, Adverse reactions | CALCITONIN SALMON |
| Calcitonin Salmon | CALCITONIN SALMON | Par Health USA, LLC | ece693d8-1832-4b85-8736-819163ba56c1 | 2017-10-01 | Warnings, Adverse reactions | CALCITONIN SALMON |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-6320 | calcitonin salmon | calcitonin salmon | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |